Literature DB >> 25261485

IL-22 fate reporter reveals origin and control of IL-22 production in homeostasis and infection.

Helena Ahlfors1, Peter J Morrison1, João H Duarte1, Ying Li1, Judit Biro1, Mauro Tolaini1, Paola Di Meglio1, Alexandre J Potocnik1, Brigitta Stockinger2.   

Abstract

IL-22 is a cytokine that regulates tissue homeostasis at barrier surfaces. A variety of IL-22-producing cell types is known, but identification on the single-cell level remains difficult. Therefore, we generated a fate reporter mouse that would allow the identification of IL-22-producing cells and their fate mapping in vivo. To trace IL-22-expressing cells, a sequence encoding Cre recombinase was cloned into the Il22 locus, and IL22(Cre) mice were crossed with reporter mice expressing enhanced yellow fluorescence protein (eYFP) under control of the endogenous Rosa26 promoter. In IL22(Cre)R26R(eYFP) mice, the fluorescent reporter permanently labels cells that have switched on Il22 expression, irrespective of cytokine production. Despite a degree of underreporting, eYFP expression was detectable in nonimmune mice and restricted to group 3 innate lymphoid cells (ILC3) in the gut and γδ T cells in skin or lung. Upon skin challenge with imiquimod, eYFP(+) γδ and CD4 T cells expanded in the skin. Infection with Citrobacter rodentium initially was controlled by ILC3, followed by expansion of eYFP(+) CD4 T cells, which were induced in innate lymphoid follicles in the colon. No eYFP expression was detected in small intestinal Th17 cells, and they did not expand in the immune response. Colonic eYFP(+) CD4 T cells exhibited plasticity during infection with expression of additional cytokines, in contrast to ILC3, which remained largely stable. Single-cell quantitative PCR analysis of eYFP(+) CD4 T cells confirmed their heterogeneity, suggesting that IL-22 expression is not confined to particular subsets or a dedicated Th22 subset.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25261485      PMCID: PMC4201943          DOI: 10.4049/jimmunol.1401244

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

1.  IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia.

Authors:  Shean J Aujla; Yvonne R Chan; Mingquan Zheng; Mingjian Fei; David J Askew; Derek A Pociask; Todd A Reinhart; Florencia McAllister; Jennifer Edeal; Kristi Gaus; Shahid Husain; James L Kreindler; Patricia J Dubin; Joseph M Pilewski; Mike M Myerburg; Carol A Mason; Yoichiro Iwakura; Jay K Kolls
Journal:  Nat Med       Date:  2008-02-10       Impact factor: 53.440

2.  Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles.

Authors:  Elina A Kiss; Cedric Vonarbourg; Stefanie Kopfmann; Elias Hobeika; Daniela Finke; Charlotte Esser; Andreas Diefenbach
Journal:  Science       Date:  2011-10-27       Impact factor: 47.728

3.  CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut.

Authors:  Gregory F Sonnenberg; Laurel A Monticelli; M Merle Elloso; Lynette A Fouser; David Artis
Journal:  Immunity       Date:  2010-12-30       Impact factor: 31.745

4.  IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration.

Authors:  Stephan Brand; Florian Beigel; Torsten Olszak; Kathrin Zitzmann; Sören T Eichhorst; Jan-Michel Otte; Helmut Diepolder; Andreas Marquardt; Wolfgang Jagla; Andreas Popp; Stéphane Leclair; Karin Herrmann; Julia Seiderer; Thomas Ochsenkühn; Burkhard Göke; Christoph J Auernhammer; Julia Dambacher
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-04       Impact factor: 4.052

5.  IL-22 increases the innate immunity of tissues.

Authors:  Kerstin Wolk; Stefanie Kunz; Ellen Witte; Markus Friedrich; Khusru Asadullah; Robert Sabat
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

6.  The transcription factors T-bet and Runx are required for the ontogeny of pathogenic interferon-γ-producing T helper 17 cells.

Authors:  Yan Wang; Jernej Godec; Khadija Ben-Aissa; Kairong Cui; Keji Zhao; Alexandra B Pucsek; Yun Kyung Lee; Casey T Weaver; Ryoji Yagi; Vanja Lazarevic
Journal:  Immunity       Date:  2014-02-13       Impact factor: 31.745

Review 7.  Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease.

Authors:  Gregory F Sonnenberg; David Artis
Journal:  Immunity       Date:  2012-10-19       Impact factor: 31.745

8.  Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions.

Authors:  Paola Di Meglio; João H Duarte; Helena Ahlfors; Nick D L Owens; Ying Li; Federica Villanova; Isabella Tosi; Keiji Hirota; Frank O Nestle; Ulrich Mrowietz; Michael J Gilchrist; Brigitta Stockinger
Journal:  Immunity       Date:  2014-06-05       Impact factor: 31.745

9.  Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells.

Authors:  Marc Veldhoen; Keiji Hirota; Jillian Christensen; Anne O'Garra; Brigitta Stockinger
Journal:  J Exp Med       Date:  2008-12-29       Impact factor: 14.307

Review 10.  Innate lymphoid cells--a proposal for uniform nomenclature.

Authors:  Hergen Spits; David Artis; Marco Colonna; Andreas Diefenbach; James P Di Santo; Gerard Eberl; Shigeo Koyasu; Richard M Locksley; Andrew N J McKenzie; Reina E Mebius; Fiona Powrie; Eric Vivier
Journal:  Nat Rev Immunol       Date:  2013-02       Impact factor: 53.106

View more
  52 in total

Review 1.  CD4+ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm.

Authors:  Kiyoshi Hirahara; Toshinori Nakayama
Journal:  Int Immunol       Date:  2016-02-12       Impact factor: 4.823

Review 2.  Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease.

Authors:  Michel DuPage; Jeffrey A Bluestone
Journal:  Nat Rev Immunol       Date:  2016-02-15       Impact factor: 53.106

Review 3.  Regulation of human helper T cell subset differentiation by cytokines.

Authors:  Nathalie Schmitt; Hideki Ueno
Journal:  Curr Opin Immunol       Date:  2015-04-11       Impact factor: 7.486

Review 4.  Citrobacter rodentium: a model enteropathogen for understanding the interplay of innate and adaptive components of type 3 immunity.

Authors:  D J Silberger; C L Zindl; C T Weaver
Journal:  Mucosal Immunol       Date:  2017-06-14       Impact factor: 7.313

5.  Visualization of IL-22-expressing Lymphocytes Using Reporter Mice.

Authors:  Wei Shen; Wenqing Li; Julie A Hixon; Caroline Andrews; Scott K Durum
Journal:  J Vis Exp       Date:  2017-01-25       Impact factor: 1.355

Review 6.  Do Memory CD4 T Cells Keep Their Cell-Type Programming: Plasticity versus Fate Commitment? Epigenome: A Dynamic Vehicle for Transmitting and Recording Cytokine Signaling.

Authors:  John L Johnson; Golnaz Vahedi
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-03-01       Impact factor: 10.005

Review 7.  The dichotomous nature of T helper 17 cells.

Authors:  Brigitta Stockinger; Sara Omenetti
Journal:  Nat Rev Immunol       Date:  2017-05-30       Impact factor: 53.106

Review 8.  Mucosal immunity to pathogenic intestinal bacteria.

Authors:  Araceli Perez-Lopez; Judith Behnsen; Sean-Paul Nuccio; Manuela Raffatellu
Journal:  Nat Rev Immunol       Date:  2016-02-22       Impact factor: 53.106

9.  HIV-2 infection is associated with preserved GALT homeostasis and epithelial integrity despite ongoing mucosal viral replication.

Authors:  S M Fernandes; A R Pires; P Matoso; C Ferreira; H Nunes-Cabaço; L Correia; E Valadas; J Poças; P Pacheco; H Veiga-Fernandes; R B Foxall; A E Sousa
Journal:  Mucosal Immunol       Date:  2017-05-17       Impact factor: 7.313

10.  IL-36R signaling integrates innate and adaptive immune-mediated protection against enteropathogenic bacteria.

Authors:  Vu L Ngo; Hirohito Abo; Michal Kuczma; Edyta Szurek; Nora Moore; Oscar Medina-Contreras; Asma Nusrat; Didier Merlin; Andrew T Gewirtz; Leszek Ignatowicz; Timothy L Denning
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.